These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14335968)

  • 21. [Clinical experimentation with a new phenothiazine derivative, propericiazine (Neuleptil), on a group of patients affected by schizophrenia and deliriant psychoses].
    Ghedini G
    Minerva Med; 1967 Jan; 58(6):131-41. PubMed ID: 4381122
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of oligophrenic children and adolescents with propericiazine].
    Dostál T
    Act Nerv Super (Praha); 1968 Oct; 10(3):319. PubMed ID: 4387432
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sociopsychological aspects of the introduction of a new psychotropic drug in a closed hospital service. Methodological reflections concerning 52 patients treated with propericiazine].
    Garneret N; Boissenin JM; Muyard JP
    Encephale; 1965; 54(3):265-83. PubMed ID: 4378570
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical trial of prothipendyl in child neuropsychiatry].
    MICHAUX L; DUCHE DJ; PRINGUET G
    Rev Neuropsychiatr Infant; 1962; 10():139-58. PubMed ID: 14473383
    [No Abstract]   [Full Text] [Related]  

  • 25. [EXPERIMENTAL USE OF 8909 RP, A NEW PHENOTHIAZINE COMPOUND, FOR THE TREATMENT OF MENTAL DISORDERS].
    TOMINAGA J; OKADA M; SUZUKI R; MATSUKI T
    Saishin Igaku; 1965 Jan; 20():236-9. PubMed ID: 14319011
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical study of a new neuroleptic drug: propericiazine (FI 6145)].
    Grava C; Bressani F
    G Psichiatr Neuropatol; 1966; 94(3):817-26. PubMed ID: 4381171
    [No Abstract]   [Full Text] [Related]  

  • 27. [Propericiazine and behavior disorders in neurological diseases in childhood and adolescence].
    Giménez Roldán S; Campos Castelló J
    Arch Neurobiol (Madr); 1969; 32(3):331-46. PubMed ID: 4392861
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bad character and Neuleptil. Apropos of a Belgian and Luxembourgian clinical experiment (1963-1964)].
    Bobon J; Gernay JM; Collard J; Goffioul F; Breulet M
    Acta Neurol Psychiatr Belg; 1968 Feb; 68(2):154-62. PubMed ID: 4387055
    [No Abstract]   [Full Text] [Related]  

  • 29. [Utilization of propericiazine in treatment of character disorders in mentally retarded children and adolescents].
    Vaneck L
    Rev Neuropsychiatr Infant; 1969 Aug; 17(8):557-61. PubMed ID: 4391428
    [No Abstract]   [Full Text] [Related]  

  • 30. [The psycholeptic drugs infantile neuropsychiatry].
    SCHULLER E
    Rev Neuropsychiatr Infant; 1961; 9():294-302. PubMed ID: 13909462
    [No Abstract]   [Full Text] [Related]  

  • 31. [2 and one half year study on FH 040 in child neuropsychiatry. Clinical and electroencephalographic data on 70 cases].
    Faure H; Faure-Martinet ML
    Rev Neuropsychiatr Infant; 1969 Dec; 17(12):853-8. PubMed ID: 5369059
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical studies with propericiazine (R.P. 8909).
    St Jean A; Sterlin C; Noe W; Ban TA
    Dis Nerv Syst; 1967 Aug; 28(8):526-31. PubMed ID: 4383004
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiences with propericiazine in the treatment of functional psychomotor disorders and states of restlessness in childhood].
    Seebandt G
    Arzneimittelforschung; 1970 Jul; 20(7):937-9. PubMed ID: 4394249
    [No Abstract]   [Full Text] [Related]  

  • 34. [Selectivity of action of propericiazine in behavior disorders].
    Nardini L; Pistoni A
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Apr; 91(2):569-75. PubMed ID: 4384082
    [No Abstract]   [Full Text] [Related]  

  • 35. [A comparative study of propericiazine in the management of antisocial behavior].
    Ferguson K; Ban TA; Lehmann HE; Lee H
    Union Med Can; 1967 Apr; 96(4):448-9. PubMed ID: 4382825
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical studies with propericiazine].
    Eckmann F; Immich H; Schäpperle O; Schwarz H
    Med Klin; 1966 Jan; 61(4):142-3. PubMed ID: 4383257
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tissue therapy in infantile neuropsychiatry].
    DONELLI A
    Clin Pediatr (Bologna); 1956 Jun; 38(6):431-61. PubMed ID: 13365106
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical remarks on the therapeutic activity of propericiazine].
    Nava V
    G Psichiatr Neuropatol; 1967; 95(1):127-51. PubMed ID: 4386098
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of the combination of propericiazine with chlorpromazine in the psychiatric field].
    Ostaptzeff G; Ostaptzeff-Lavoine M
    Ann Med Psychol (Paris); 1965 Dec; 123(5):655-64. PubMed ID: 4379140
    [No Abstract]   [Full Text] [Related]  

  • 40. [A NEW NEUROLEPTIC IN GERIATRIC PSYCHIATRY: PROPERCIAZINE].
    MARS G; NECCHIDELLASILVA A
    G Gerontol; 1964 May; 12():647-54. PubMed ID: 14195477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.